Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis
出版年份 2018 全文链接
标题
Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis
作者
关键词
-
出版物
Emerging Microbes & Infections
Volume 7, Issue 1, Pages -
出版商
Informa UK Limited
发表日期
2018-12-04
DOI
10.1038/s41426-018-0205-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna
- (2018) Selma Tobudic et al. CLINICAL INFECTIOUS DISEASES
- Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen
- (2018) B.J. Werth et al. CLINICAL MICROBIOLOGY AND INFECTION
- Unsuccessful treatment of methicillin-resistant Staphylococcus aureus endocarditis with dalbavancin
- (2017) J. M. Steele et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Growthcurver: an R package for obtaining interpretable metrics from microbial growth curves
- (2016) Kathleen Sprouffske et al. BMC BIOINFORMATICS
- In vitro activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infections
- (2016) Javier Fernández et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Emergence of a small colony variant of vancomycin-intermediateStaphylococcus aureusin a patient with septic arthritis during long-term treatment with daptomycin
- (2016) Yu-Tzu Lin et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Wavelength-normalized spectroscopic analysis of Staphylococcus aureus and Pseudomonas aeruginosa growth rates
- (2016) Samantha E. McBirney et al. Biomedical Optics Express
- Surrogate analysis of vancomycin to predict susceptible categorization of dalbavancin
- (2015) Ronald N. Jones et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Vancomycin intermediate-Resistant Staphylococcus aureus (VISA) Isolated from a patient who never received Vancomycin treatment
- (2015) Xuhui Zhu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Use of vancomycin as a surrogate for dalbavancin in vitro susceptibility testing: results from the DISCOVER studies
- (2015) Michael W Dunne et al. Annals of Clinical Microbiology and Antimicrobials
- A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
- (2015) Laura M. Koeth et al. Jove-Journal of Visualized Experiments
- Trimmomatic: a flexible trimmer for Illumina sequence data
- (2014) Anthony M. Bolger et al. BIOINFORMATICS
- Clinical Characteristics and Outcomes of Prosthetic Joint Infection Caused by Small Colony Variant Staphylococci
- (2014) A. J. Tande et al. mBio
- The MaSuRCA genome assembler
- (2013) Aleksey V. Zimin et al. BIOINFORMATICS
- Mutations in rpoB and fusA cause resistance to rifampicin and fusidic acid in methicillin-resistant Staphylococcus aureus strains from a tertiary hospital in Malaysia
- (2013) K.-T. Lim et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Contribution of Selected Gene Mutations to Resistance in Clinical Isolates of Vancomycin-Intermediate Staphylococcus aureus
- (2012) Cory Hafer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Unipro UGENE: a unified bioinformatics toolkit
- (2012) Konstantin Okonechnikov et al. BIOINFORMATICS
- Serine/Threonine Phosphatase Stp1 Contributes to Reduced Susceptibility to Vancomycin and Virulence in Staphylococcus aureus
- (2012) David R. Cameron et al. JOURNAL OF INFECTIOUS DISEASES
- Genetic Pathway in Acquisition and Loss of Vancomycin Resistance in a Methicillin Resistant Staphylococcus aureus (MRSA) Strain of Clonal Type USA300
- (2012) Susana Gardete et al. PLoS Pathogens
- Small colony variants of Staphylococcus aureus — review
- (2011) O. Melter et al. FOLIA MICROBIOLOGICA
- Impact of rpoB Mutations on Reduced Vancomycin Susceptibility in Staphylococcus aureus
- (2011) Yukiko Watanabe et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Emergence of NDM-1-positive capsulated Escherichia coli with high resistance to serum killing in Japan
- (2011) Tatsuo Yamamoto et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- c-di-AMP Is a New Second Messenger in Staphylococcus aureus with a Role in Controlling Cell Size and Envelope Stress
- (2011) Rebecca M. Corrigan et al. PLoS Pathogens
- Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR
- (2011) Benjamin P. Howden et al. PLoS Pathogens
- New Lipoglycopeptides
- (2010) George G. Zhanel et al. DRUGS
- Identification of differentially expressed small non-protein-coding RNAs in Staphylococcus aureus displaying both the normal and the small-colony variant phenotype
- (2010) Luay F. Abu-Qatouseh et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Antibacterial properties of zeylasterone, a triterpenoid isolated from Maytenus blepharodes, against Staphylococcus aureus
- (2010) L. de León et al. MICROBIOLOGICAL RESEARCH
- Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR
- (2009) Y. Kato et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Genomic Analysis Reveals a Point Mutation in the Two-Component Sensor Gene graS That Leads to Intermediate Vancomycin Resistance in Clinical Staphylococcus aureus
- (2008) B. P. Howden et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More